TransMedics Group Inc (TMDX)
Official siteHEALTHCARE • MEDICAL DEVICES • NASDAQ
Market Cap: $3.20B
Last updated: Nov 17, 2026 at 4:30 PM ET
TransMedics Group Inc (TMDX) Stock Chart
TransMedics Group (TMDX) has a latest price of $93.91 on Nov 17, 2026, 39.8% below its 52-week high of $156.00. Its price fell 18.3% over the past 12 months. The month-end price rose 140.6% over the 5 years through Oct 2026, a compound annual rate of 19.2%.
Price Chart
From May 2019 to Oct 2026, its highest month-end close was $168.06 in Aug 2024 and its lowest $11.98 in Oct 2020, adjusted for splits.
Month-end closes, adjusted for splits. Dividends are not included.
Chart TMDX with Advanced Charting
Daily candlesticks, valuation multiples, side-by-side comparisons and drawings for TMDX.
Free with a GNG account. No credit card.
Price Performance
Over the past 3 months the price fell 0.1%, and over 6 months it rose 42.0%. The month-end price rose 76.1% over the 3 years through Oct 2026, a compound annual rate of 20.8%.
| Period | Change |
|---|---|
| 1 month | +31.2% |
| 3 months | -0.1% |
| 6 months | +42.0% |
| 12 months | -18.3% |
| 12 months, with dividends | -18.3% |
| Period | Change | Per year |
|---|---|---|
| 3 years | +76.1% | +20.8% |
| 5 years | +140.6% | +19.2% |
Price by Year
Its best calendar year was 2022, when the price rose 222.1%, and its weakest was 2024, when it fell 21.0%.
| Year | Close | Change |
|---|---|---|
| 2026 through Oct 2026 | $65.99 | -45.8% |
| 2025 | $121.65 | +95.1% |
| 2024 | $62.35 | -21.0% |
| 2023 | $78.93 | +27.9% |
| 2022 | $61.72 | +222.1% |
| 2021 | $19.16 | -3.7% |
| 2020 | $19.90 | +4.7% |
Trading Range
The price is 16.7% above its 50-day average of $80.44 and 2.9% above its 200-day average of $91.22.
| Measure | Value | Price vs |
|---|---|---|
| Latest price (Nov 17, 2026) | $93.91 | |
| 52-week high | $156.00 | -39.8% |
| 52-week low | $60.10 | +56.3% |
| 50-day average | $80.44 | +16.7% |
| 200-day average | $91.22 | +2.9% |
Price Risk
Over 3 years, its largest fall from a peak was 67.8%.
| Measure | Value |
|---|---|
| 1-year beta | 1.20 |
| Largest fall, 1 year | -58.8% |
| Largest fall, 3 years | -67.8% |
Advanced Charting Features
Advanced Charting is free with a GNG account, and signed-in members get it in place of the price chart above.
- Valuation multiples. Daily P/E, price to sales, cash flow and book value, PEG and PEGY, drawn behind the price wherever the company's data supports them.
- Price charts and drawings. Candlestick, OHLC, line and area charts with volume and earnings, dividend and split markers, plus trend lines, levels and notes kept in your account.
- Side-by-side compare. Two stocks next to each other on one metric and time span, each chart with its own price scale.
- Projections and saved views. Pick a start and an end point to see the price return, dividends and total return between them, and save views to open later.
Frequently Asked Questions About TMDX
What is TMDX's 1-year price change?
TransMedics Group's price fell 18.3% over the past 12 months. With dividends included, the 12-month total return was -18.3%.
What is TMDX's 5-year price change?
TransMedics Group's month-end price rose 140.6% over the 5 years through Oct 2026, a compound annual rate of 19.2%. These figures leave out dividends.
What is TMDX's 52-week high and low?
TransMedics Group's 52-week high is $156.00 and its 52-week low is $60.10. Its latest price of $93.91 on Nov 17, 2026 is 39.8% below the high.
What is TMDX's beta?
TransMedics Group's 1-year beta against the S&P 500 is 1.20, so its price has moved more than the market over the past year. Its largest fall from a peak over the past year was 58.8%.
Is the TMDX chart free?
Yes. Advanced Charting for TMDX is free with a GNG account, and no credit card is needed. It adds daily candlestick and line charts with volume, valuation multiples, side-by-side comparisons, drawings and saved views.
TMDX pages: Overview, Charting, Earnings, Forecast, Financials, Statistics, Valuation, Competitors